Correlation Between Zivo Bioscience and Foghorn Therapeutics
Can any of the company-specific risk be diversified away by investing in both Zivo Bioscience and Foghorn Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zivo Bioscience and Foghorn Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zivo Bioscience and Foghorn Therapeutics, you can compare the effects of market volatilities on Zivo Bioscience and Foghorn Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zivo Bioscience with a short position of Foghorn Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zivo Bioscience and Foghorn Therapeutics.
Diversification Opportunities for Zivo Bioscience and Foghorn Therapeutics
0.27 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Zivo and Foghorn is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Zivo Bioscience and Foghorn Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Foghorn Therapeutics and Zivo Bioscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zivo Bioscience are associated (or correlated) with Foghorn Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Foghorn Therapeutics has no effect on the direction of Zivo Bioscience i.e., Zivo Bioscience and Foghorn Therapeutics go up and down completely randomly.
Pair Corralation between Zivo Bioscience and Foghorn Therapeutics
Given the investment horizon of 90 days Zivo Bioscience is expected to under-perform the Foghorn Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Zivo Bioscience is 1.27 times less risky than Foghorn Therapeutics. The stock trades about -0.03 of its potential returns per unit of risk. The Foghorn Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 657.00 in Foghorn Therapeutics on August 27, 2024 and sell it today you would earn a total of 127.00 from holding Foghorn Therapeutics or generate 19.33% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 31.85% |
| Values | Daily Returns |
Zivo Bioscience vs. Foghorn Therapeutics
Performance |
| Timeline |
| Zivo Bioscience |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Foghorn Therapeutics |
Zivo Bioscience and Foghorn Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Zivo Bioscience and Foghorn Therapeutics
The main advantage of trading using opposite Zivo Bioscience and Foghorn Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zivo Bioscience position performs unexpectedly, Foghorn Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Foghorn Therapeutics will offset losses from the drop in Foghorn Therapeutics' long position.| Zivo Bioscience vs. RenovoRx | Zivo Bioscience vs. Pasithea Therapeutics Corp | Zivo Bioscience vs. Quoin Pharmaceuticals Ltd | Zivo Bioscience vs. Erasca Inc |
| Foghorn Therapeutics vs. Eliem Therapeutics | Foghorn Therapeutics vs. HCW Biologics | Foghorn Therapeutics vs. Scpharmaceuticals | Foghorn Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |